The honest answer is: It depends entirely on which product you're talking about, and the gap between the best- and worst-supported options on the market is much larger than marketing on both sides would have you believe. Here is what the evidence actually shows, category by category.
Melatonin: really effective, but only for a specific problem
Melatonin has one of the larger evidence bases of all sleep supplements, but its effectiveness is specific to circadian timing issues, jet lag, shift work, and a delayed sleep window, not insomnia in general. Clinical research supports doses in the range of 0.5 to 3 milligrams, significantly less than many commercial products now contain, and higher doses have not shown significantly better results. For someone whose sleep problem is truly circadian, the evidence is solid. For someone whose problem is driven by stress or respiratory issues, melatonin addresses a mechanism that was never the cause.
Magnesium: moderate support, often exaggerated
For magnesium, there is clinical evidence for improved sleep quality, especially in people with magnesium deficiency and older adults. The suspected mechanism is its role in regulating GABA, a calming neurotransmitter. The effect sizes in the available studies are overall moderate, and much of the more dramatic marketing around magnesium in the current wellness market overstates the actual state of research.
Valerian and herbal blends: weak, inconsistent evidence
Valerian is one of the most commonly used herbal sleep aids, and at the same time, one of the most inconsistently supported. Systematic reviews of valerian studies find mixed results, with some studies showing moderate benefits and others no significant difference from placebo. Researchers usually attribute this pattern to inconsistent extraction methods and dosages of the various products; there is no definitive answer as to whether the plant itself works.
CBD: promising, but still very early
Research on CBD for sleep is growing rapidly, but clinical evidence in humans remains comparatively limited. Most existing studies have small sample sizes or measure anxiety instead of sleep directly. Early research points to a possible benefit, especially for sleep disorders related to anxiety, but sleep researchers remain generally cautious about treating CBD as an established sleep intervention, because current market hype has significantly outpaced the size and quality of the evidence base.
Weighted blankets: moderate, real, but limited evidence
Several smaller studies show that weighted blankets can improve subjective sleep quality and reduce time to fall asleep. The suspected mechanism is deep pressure stimulation and its effect on the nervous system. The evidence is real, but limited in scope, and the effect appears to be more pronounced for anxiety-related sleep problems than for sleep disorders with other causes.
Sleep trackers: useful for patterns, not diagnoses
Consumer sleep trackers have gotten significantly better, but validation studies comparing them to clinical polysomnography still find relevant inaccuracies, especially in precisely distinguishing sleep stages. Their true value lies in recognizing patterns over time—a regular drop in sleep quality during a specific week of the cycle, a consistent disruption after alcohol—not in a clinically precise night-by-night analysis.
Nasal strips and respiratory aids: real mechanism, evidence for broad use still emerging
The mechanism behind nasal strips, supporting airflow through a mechanically narrowed nasal passage, is well documented in respiratory physiology. Less clear is how much someone without a noticeable narrowing benefits from nighttime use. The honest position, also held by sleep physicians, on this category: The tool is clearest useful for people with an identifiable restriction of nasal airflow, not as a universal nighttime add-on with guaranteed benefits for everyone.
Where NMN stands in this assessment
NMN belongs in a different category than most of the above, because its target is not sleep directly, but NAD+, the coenzyme that activates SIRT1, the protein behind the precision of the circadian clock. The clinical evidence base is smaller than for melatonin, but mechanistically more specific than for most herbal options: A randomized, double-blind, placebo-controlled study from 2022 in the journal Nutrients found significant improvements in sleep quality scores in adults who took NMN daily for twelve weeks. As with most of the categories above: The research base is real, but still emerging compared to more established interventions, and any claim that goes beyond what the published studies themselves report deserves the same skepticism as in any other category on this list.
The honest assessment framework for all of it
The products with the strongest evidence share three characteristics: a concrete, identified mechanism, a dose that corresponds to what was actually studied, and a defined target group in which the research took place. A product that promises broad, dramatic benefits for everyone, in a dose or formulation that has never been directly tested, makes a claim that the evidence does not support, regardless of the category. The question worth asking is never simply "does it work". It is "for which specific problem, in which target group, in which dose was this actually shown", because that is exactly the question most sleep marketing tries to avoid.
